Company
BBOT
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Redefining what’s possible in precision oncology to treat RAS-dependent cancers. Inhibiting Active RAS. Going beyond current approaches.
Loading relationship preview